APM
PFE icon

Avidity Partners Management’s Pfizer PFE Stock Holding History

Avidity Partners Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-6,851,000
Closed -$239M – 113
2020
Q3 		$239M Buy
+6,851,000
New +$240M 11.06% 1

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Avidity Partners Management's PFE Position: Q1 2026 in Review

Avidity Partners Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 203,600 shares — an estimated $5.07M sold.

Avidity Partners Management first reported a position in PFE in Q3 2021 and held it in 5 quarters. The position peaked at $123M in Q4 2021. 2,963 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Avidity Partners Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Avidity Partners Management sold 203,600 Pfizer shares in Q1 2026, an estimated $5.07M.
  • Avidity Partners Management first reported a position in Pfizer in Q3 2021 and held it in 5 quarters.
  • Avidity Partners Management's Pfizer position peaked at $123M in Q4 2021.
  • 2,963 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Avidity Partners Management's 13F filing for Q1 2026, filed 13 May 2026.